• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Cipla Reports Strong Quarterly Profits Driven by Domestic Demand

Rashmi NSH by Rashmi NSH
1 year ago
in Science News, Pharmaceutical & Chemical
0
Cipla

Indian drugmaker Cipla has announced impressive financial results for the April to June quarter, surpassing analysts’ expectations. The company’s net profit rose by 10%, reaching 12.98 billion rupees (approximately $150 million). This success comes as strong domestic demand for Cipla’s generic respiratory drugs boosts sales in India.

Cipla is India’s third-largest drug company by sales, and India remains its biggest market. Revenue from the Indian market increased by 6%, totaling 30.70 billion rupees. However, the company’s revenue from North America fell by 7%, bringing in only 19.33 billion rupees. Together, these two regions account for around 75% of Cipla’s total sales.

Despite the drop in North American revenue, Cipla’s overall total revenue increased by 4% to 69.57 billion rupees. This was slightly lower than analysts’ projected expectations of 70.64 billion rupees. Following the positive earnings report, Cipla’s stock price rose by 3.4%, making it the top gainer on the Nifty 50 index, a leading stock market index in India.

The growth in India was largely driven by strong demand for drugs in various therapy areas, including respiratory, urology, and anti-infectives. Nonetheless, Cipla faces challenges in the U.S. market, including delays in new drug approvals and ongoing pricing pressure. Analysts predict that drug prices in the U.S. may decrease as market shortages ease and new competitors enter.

Earlier this week, rival company Dr. Reddy’s Laboratories reported disappointing quarterly results and highlighted increasing price competition for key products, such as lenalidomide in North America.

With a solid performance this quarter, Cipla is positioned to navigate the complexities of the global pharmaceutical landscape while focusing on addressing needs in its core domestic market.

-Rashmi Kumari

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: featuredsciencenews
Rashmi NSH

Rashmi NSH

Other Posts

Bar chart of decreasing bars beside a line-art antibiotic icon

When the Last Antibiotic Fails: ICMR Finds 91 Per Cent Carbapenem Resistance in a Common Hospital Pathogen

November 21, 2026
0
Map of India's east coast with a stylised cyclone and its forecast track

Akvan Turns North and Drops a Category: IMD Now Expects a Severe Cyclone Between Narsapur and Puri, While Andhra’s Own Forecasters Expect Less

November 21, 2026
0

Antalya’s Last Forty-Eight Hours: Two Contradictory Paragraphs on Fossil Fuels, and India’s Line on the Carbon Budget

Disarm, Don’t Kill: CCMB Scientists Find Two Compounds That Stop a Deadly Fungus Turning Invasive

Eighty Per Cent of the Cost: Andhra Pradesh Raises the Stakes in India’s Chip-Subsidy Contest

Before the First Breath: UNEP and WHO Say Hormone-Disrupting Chemicals Reach Us in the Womb

The Morning Eye Closes: NASA Will Switch Off Terra After 27 Years of Watching the Planet

A Status Lost: Measles Is Endemic Again in the United States, Mexico and Bolivia

Next Post
20 Billion Years

The Universe’s Future: A Potential Collapse in 20 Billion Years

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
11

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist